|
Reference #:
2001-091
Inventors/Contributors
Jeffrey L. Platt M.D., Gregory J. Brunn Ph.D., Yuzo Kodaira M.D., Ph.D., Geoffrey B. Johnson M.D., Ph.D.
Description
We have discovered that complex saccharides, specifically heparan sulfate glycosaminoglycans, signal cells through toll-like receptors. Since toll-like receptors are thought to detect toxic compounds such as endotoxin, the finding that an endogenous saccharide can signal cells through those receptros provides a potentially non-toxic means by which cells can be stimulated. Signaling of toll-like receptors by heparan sulfate might be used to stimulate immunity, prevent cellular injury by infectiuos microorganisms or potentially suppress immune responses.
Patent Status
Pending |
|
Contact
Nathan L. Stacy, Licensing Manager
stacy.nathan@mayo.edu
|
|
Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905
|
Phone: (507) 538-1652
Fax: (507) 284-5410
|
|
|